tiprankstipranks
Kronos Bio (KRON)
NASDAQ:KRON
US Market

Kronos Bio (KRON) Financial Statements

180 Followers

Kronos Bio Financial Overview

Kronos Bio's market cap is currently ―. The company's EPS TTM is $-1.995; its P/E ratio is -0.63; Kronos Bio is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 2.50M$ 2.30M$ 917.00K$ 1.90M$ 1.20M
Gross Profit$ 2.50M$ 2.30M$ 900.00K$ 1.90M$ 1.20M
EBIT$ -29.98M$ -20.89M$ -31.39M$ -29.70M$ -26.26M
EBITDA$ -29.79M$ -16.47M$ -31.36M$ -30.09M$ -26.33M
Net Income Common Stockholders$ -29.96M$ -25.32M$ -31.37M$ -29.74M$ -26.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 151.98M$ 173.00M$ 186.71M$ 219.46M$ 226.40M
Total Assets$ 182.98M$ 213.28M$ 237.99M$ 260.62M$ 289.02M
Total Debt$ 27.47M$ 28.27M$ 29.54M$ 30.16M$ 30.98M
Net Debt$ -124.51M$ -144.72M$ -157.17M$ -189.30M$ -195.43M
Total Liabilities$ 46.01M$ 54.20M$ 59.37M$ 57.27M$ 63.42M
Stockholders Equity$ 136.97M$ 159.08M$ 178.62M$ 203.34M$ 225.60M
Cash Flow-
Free Cash Flow$ -23.91M$ -25.05M$ -22.80M$ -25.33M$ -6.04M
Operating Cash Flow$ -23.90M$ -25.02M$ -22.59M$ -25.02M$ -5.92M
Investing Cash Flow$ 5.77M$ 31.56M$ 35.79M$ 5.37M$ -6.36M
Financing Cash Flow-$ 191.00K-$ 376.00K-
Currency in USD

Kronos Bio Earnings and Revenue History

Kronos Bio Debt to Assets

Kronos Bio Cash Flow

Kronos Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis